Qing Lin

4.3k total citations · 2 hit papers
79 papers, 3.5k citations indexed

About

Qing Lin is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Qing Lin has authored 79 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 14 papers in Biomaterials and 14 papers in Biomedical Engineering. Recurrent topics in Qing Lin's work include Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (11 papers) and Nanoplatforms for cancer theranostics (11 papers). Qing Lin is often cited by papers focused on Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (11 papers) and Nanoplatforms for cancer theranostics (11 papers). Qing Lin collaborates with scholars based in China, United States and United Kingdom. Qing Lin's co-authors include Zhirong Zhang, Yu Fu, Martha C. Bohn, Ling Zhang, DL Choi-Lundberg, Beverly L. Davidson, Ya‐Wen Chiang, Yung‐Nien Chang, Xun Sun and Mengke Qu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Qing Lin

77 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy

1997 523 citations Qing Lin et al. profile →
Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease

2018 446 citations Mengke Qu, Qing Lin et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qing Lin China	28	2.1k	674	502	451	414	79	3.5k
Jagdeep K. Sandhu Canada	26	1.4k 0.7×	299 0.4×	381 0.8×	289 0.6×	181 0.4×	57	2.7k
Kamran Ghaedi Iran	37	3.4k 1.7×	316 0.5×	1.3k 2.6×	374 0.8×	345 0.8×	292	5.8k
Victoria Moreno‐Manzano Spain	29	1.4k 0.7×	747 1.1×	362 0.7×	361 0.8×	269 0.6×	104	3.1k
Nanette H. Bishopric United States	39	3.7k 1.8×	426 0.6×	944 1.9×	307 0.7×	328 0.8×	80	6.3k
Guido Lenz Brazil	38	2.1k 1.0×	373 0.6×	553 1.1×	241 0.5×	118 0.3×	134	4.3k
Arie Reijerkerk Netherlands	35	1.8k 0.9×	270 0.4×	591 1.2×	260 0.6×	231 0.6×	50	3.7k
Qianxue Chen China	35	2.0k 0.9×	373 0.6×	1.1k 2.1×	309 0.7×	196 0.5×	237	4.5k
Xing Wei China	33	1.1k 0.5×	270 0.4×	206 0.4×	203 0.5×	381 0.9×	122	3.3k
Yaqiao Li United States	21	2.5k 1.2×	279 0.4×	390 0.8×	230 0.5×	180 0.4×	49	4.3k

Countries citing papers authored by Qing Lin

Since Specialization

Citations

This map shows the geographic impact of Qing Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Lin more than expected).

Fields of papers citing papers by Qing Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Lin. The network helps show where Qing Lin may publish in the future.

Co-authorship network of co-authors of Qing Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Lin. A scholar is included among the top collaborators of Qing Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Lin. Qing Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yujia, Hanming Zhang, Shiqi Huang, et al.. (2024). Replacing cholesterol with asiatic acid to prolong circulation and enhance anti-metastatic effects of non-PEGylated liposomes. Journal of Controlled Release. 366. 585–595. 13 indexed citations

Wang, Leilei, Rong Liu, Yuan Xue, et al.. (2023). A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment. Acta Pharmaceutica Sinica B. 14(5). 2263–2280. 27 indexed citations

Jia, Na, Yunzhen Gao, Min Li, et al.. (2023). Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms. Signal Transduction and Targeted Therapy. 8(1). 280–280. 87 indexed citations

Chen, Xinyue, Yi Wang, Yujie Xie, et al.. (2022). HOTAIR/miR-203/CAV1 Crosstalk Influences Proliferation, Migration, and Invasion in the Breast Cancer Cell. International Journal of Molecular Sciences. 23(19). 11755–11755. 20 indexed citations

Li, Min, Lan Yang, Yan Zhang, et al.. (2022). Biopharmaceutical, preclinical pharmacokinetic and pharmaco-dynamic investigations of an orally administered novel 3-nbutylphthalide prodrug for ischemic stroke treatment. European Journal of Pharmaceutical Sciences. 180. 106308–106308. 1 indexed citations

Yang, Lan, Xiaomin Xu, Min Li, et al.. (2021). Multifunctional Size-Expandable Nanomedicines Enhance Tumor Accumulation and Penetration for Synergistic Chemo-Photothermal Therapy. ACS Applied Materials & Interfaces. 13(39). 46361–46374. 15 indexed citations

Fu, Yu, Leilei Wang, Wei Liu, et al.. (2021). OX40L blockade cellular nanovesicles for autoimmune diseases therapy. Journal of Controlled Release. 337. 557–570. 10 indexed citations

Fu, Yu, Qing Lin, Zhirong Zhang, & Ling Zhang. (2019). Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity. Acta Pharmaceutica Sinica B. 10(3). 414–433. 185 indexed citations

Liu, Wei, Qing Lin, Yu Fu, et al.. (2019). Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment. Journal of Controlled Release. 323. 191–202. 88 indexed citations

10.

Qu, Mengke, Qing Lin, Luyi Huang, et al.. (2018). Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease. Journal of Controlled Release. 287. 156–166. 446 indexed citations breakdown →

11.

Chen, Qing, Yunshu Lu, Yijun Jia, et al.. (2017). An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts. PLoS ONE. 12(1). e0168960–e0168960. 8 indexed citations

12.

Li, Liang, et al.. (2016). [Effect of Dangua Recipe on Hepatic Adiponectin Receptor 2 Expression in Diabetic Apolipoprotein E Knockout Mice].. PubMed. 36(9). 1097–1102. 2 indexed citations

13.

Lin, Qing, et al.. (2015). Intestinal absorption characteristics of imperialine: in vitro and in situ assessments. Acta Pharmacologica Sinica. 36(7). 863–873. 20 indexed citations

14.

Jia, Yijun, Lei Xu, Qing Lin, et al.. (2014). Levels of lymphocyte subsets in peripheral blood prior treatment are associated with aggressive breast cancer phenotypes or subtypes. Medical Oncology. 31(6). 981–981. 15 indexed citations

15.

Wang, Xinyi, Quan Zhang, Qing Lin, Yue Zhang, & Zhirong Zhang. (2014). Validated LC–MS/MS method for the simultaneous determination of chlorambucil and its prodrug in mouse plasma and brain, and application to pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis. 99. 74–78. 6 indexed citations

16.

Lin, Qing, Quan Zhang, Xu Song, et al.. (2013). Novel LC–MS/MS method for analyzing imperialine in rat plasma: Development, validation, and application to pharmacokinetics. Journal of Chromatography B. 938. 51–59. 15 indexed citations

17.

Lin, Qing, Sebastian Weis, Guang Yang, et al.. (2007). Catalytic inactive heme oxygenase-1 protein regulates its own expression in oxidative stress. Free Radical Biology and Medicine. 44(5). 847–855. 55 indexed citations

18.

Lin, Qing, Sebastian Weis, Guang Yang, et al.. (2007). Heme Oxygenase-1 Protein Localizes to the Nucleus and Activates Transcription Factors Important in Oxidative Stress. Journal of Biological Chemistry. 282(28). 20621–20633. 356 indexed citations

19.

Chen, Qi, Lan Lin, Sheryl T. Smith, Qing Lin, & Jumin Zhou. (2005). Multiple Promoter Targeting Sequences exist in Abdominal-B to regulate long-range gene activation. Developmental Biology. 286(2). 629–636. 32 indexed citations

20.

Lin, Qing, Qi Chen, Lan Lin, & Jumin Zhou. (2004). The Promoter Targeting Sequence mediates epigenetically heritable transcription memory. Genes & Development. 18(21). 2639–2651. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact